JP2006512413A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006512413A5 JP2006512413A5 JP2005502554A JP2005502554A JP2006512413A5 JP 2006512413 A5 JP2006512413 A5 JP 2006512413A5 JP 2005502554 A JP2005502554 A JP 2005502554A JP 2005502554 A JP2005502554 A JP 2005502554A JP 2006512413 A5 JP2006512413 A5 JP 2006512413A5
- Authority
- JP
- Japan
- Prior art keywords
- types
- group
- hpv
- use according
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000022361 Human papillomavirus infectious disease Diseases 0.000 claims 10
- 230000008696 hypoxemic pulmonary vasoconstriction Effects 0.000 claims 10
- 201000010099 disease Diseases 0.000 claims 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 7
- 208000015181 infectious disease Diseases 0.000 claims 7
- 241000341655 Human papillomavirus type 16 Species 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 4
- 239000002671 adjuvant Substances 0.000 claims 3
- 231100000590 oncogenic Toxicity 0.000 claims 3
- 230000002246 oncogenic effect Effects 0.000 claims 3
- 239000000902 placebo Substances 0.000 claims 3
- 229940068196 placebo Drugs 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 230000002163 immunogen Effects 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43503502P | 2002-12-20 | 2002-12-20 | |
| US60/435,035 | 2002-12-20 | ||
| US49665303P | 2003-08-20 | 2003-08-20 | |
| US60/496,653 | 2003-08-20 | ||
| PCT/EP2003/014562 WO2004056389A1 (en) | 2002-12-20 | 2003-12-18 | Hpv-16 and -18 l1 vlp vaccine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006512413A JP2006512413A (ja) | 2006-04-13 |
| JP2006512413A5 true JP2006512413A5 (https=) | 2007-01-25 |
| JP5475939B2 JP5475939B2 (ja) | 2014-04-16 |
Family
ID=32685362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005502554A Expired - Lifetime JP5475939B2 (ja) | 2002-12-20 | 2003-12-18 | Ｈｐｖ−１６およびｈｐｖ−１８ｌ１ｖｌｐワクチン |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US20060251676A1 (https=) |
| EP (1) | EP1572233B1 (https=) |
| JP (1) | JP5475939B2 (https=) |
| KR (3) | KR20050086924A (https=) |
| AP (1) | AP2005003347A0 (https=) |
| AR (1) | AR042530A1 (https=) |
| AT (1) | ATE503492T1 (https=) |
| AU (1) | AU2003293942B2 (https=) |
| BE (3) | BE2015C068I2 (https=) |
| BR (1) | BR0317544A (https=) |
| CA (1) | CA2510457C (https=) |
| CY (1) | CY1111552T1 (https=) |
| DE (1) | DE60336581D1 (https=) |
| DK (1) | DK1572233T3 (https=) |
| EA (2) | EA200701633A1 (https=) |
| EC (1) | ECSP055869A (https=) |
| IL (1) | IL169085A (https=) |
| IS (1) | IS2811B (https=) |
| MA (1) | MA27581A1 (https=) |
| MX (1) | MXPA05006764A (https=) |
| MY (1) | MY144492A (https=) |
| NO (1) | NO20052846L (https=) |
| NZ (1) | NZ540811A (https=) |
| OA (1) | OA13147A (https=) |
| PL (1) | PL215257B1 (https=) |
| PT (1) | PT1572233E (https=) |
| TW (1) | TWI349557B (https=) |
| WO (1) | WO2004056389A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100629028B1 (ko) * | 1998-10-16 | 2006-09-26 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 애쥬번트 시스템 및 백신 |
| GB0206360D0 (en) | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
| US7858098B2 (en) | 2002-12-20 | 2010-12-28 | Glaxosmithkline Biologicals, S.A. | Vaccine |
| JP2008502633A (ja) * | 2004-06-16 | 2008-01-31 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | Ｈｐｖ１６およびｈｐｖ１８ならびにｈｐｖ３１、４５または５２から選ばれる少なくとも１つの別のｈｐｖ型に対するワクチン |
| US7758866B2 (en) | 2004-06-16 | 2010-07-20 | Glaxosmithkline Biologicals, S.A. | Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52 |
| EP1877087B1 (en) | 2005-04-15 | 2013-02-20 | GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen |
| AR053715A1 (es) * | 2005-04-26 | 2007-05-16 | Glaxosmithkline Biolog Sa | Vacuna multivalente de vph |
| WO2006114312A2 (en) * | 2005-04-26 | 2006-11-02 | Glaxosmithkline Biologicals S.A. | Vaccine |
| WO2008134935A1 (en) | 2007-04-29 | 2008-11-13 | Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. | Truncated human papillomavirus type 18 l1 proteins |
| US9428555B2 (en) | 2007-04-29 | 2016-08-30 | Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. | Truncated L1 protein of Human Papillomavirus type 16 |
| DK2403507T3 (en) * | 2009-03-05 | 2018-06-06 | Jenny Colleen Mccloskey | TREATMENT OF INFECTION |
| CN104288763B (zh) * | 2009-06-19 | 2018-03-06 | 艾金株式会社 | 宫颈癌疫苗 |
| US20170212116A1 (en) | 2014-01-31 | 2017-07-27 | Ulisse Biomed Srl | Biosensors for the detection of infection and associated maladies |
| US10799574B2 (en) | 2014-10-24 | 2020-10-13 | Hpvvax. Llc | Method and composition for treating cancer or skin lesion using a vaccine |
| CN107001430A (zh) | 2014-10-24 | 2017-08-01 | 哈普威克斯有限责任公司 | 癌症和皮肤病变治疗 |
| WO2016194685A1 (ja) * | 2015-06-02 | 2016-12-08 | テルモ株式会社 | アルミニウムを含有するアジュバント組成物およびこれを含むワクチン組成物 |
| KR20250136930A (ko) | 2018-03-06 | 2025-09-16 | 프레시전 인코포레이티드 | 사람 파필로마바이러스 백신 및 이의 용도 |
| IL277128B2 (en) | 2018-03-06 | 2025-11-01 | Precigen Inc | Hepatitis b vaccines and uses of the same |
| WO2019233412A1 (zh) * | 2018-06-04 | 2019-12-12 | 厦门大学 | 一种人乳头瘤病毒18型l1蛋白的突变体 |
| WO2020117715A1 (en) | 2018-12-03 | 2020-06-11 | Board Of Regents, The University Of Texas System | Oligo-benzamide analogs and their use in cancer treatment |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4332596A1 (de) * | 1993-09-24 | 1995-03-30 | Martin Josef Dr Sapp | Monoklonale Antikörper |
| EP1015561B1 (en) | 1997-09-05 | 2006-07-19 | Medimmune, Inc. | In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps) |
| AU764138B2 (en) * | 1999-02-05 | 2003-08-14 | Merck Sharp & Dohme Corp. | Human papilloma virus vaccine formulations |
| US6245568B1 (en) | 1999-03-26 | 2001-06-12 | Merck & Co., Inc. | Human papilloma virus vaccine with disassembled and reassembled virus-like particles |
| GB9921146D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
| US6908613B2 (en) * | 2000-06-21 | 2005-06-21 | Medimmune, Inc. | Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
| NZ523408A (en) * | 2000-06-26 | 2006-02-24 | Stressgen Biotechnologies Corp | Human papilloma virus treatment |
-
2003
- 2003-12-18 PT PT03789346T patent/PT1572233E/pt unknown
- 2003-12-18 MX MXPA05006764A patent/MXPA05006764A/es active IP Right Grant
- 2003-12-18 KR KR1020057011497A patent/KR20050086924A/ko not_active Ceased
- 2003-12-18 AU AU2003293942A patent/AU2003293942B2/en not_active Expired
- 2003-12-18 US US10/540,099 patent/US20060251676A1/en not_active Abandoned
- 2003-12-18 MY MYPI20034868A patent/MY144492A/en unknown
- 2003-12-18 CA CA2510457A patent/CA2510457C/en not_active Expired - Lifetime
- 2003-12-18 DK DK03789346.8T patent/DK1572233T3/da active
- 2003-12-18 AR ARP030104709A patent/AR042530A1/es unknown
- 2003-12-18 TW TW092135963A patent/TWI349557B/zh not_active IP Right Cessation
- 2003-12-18 AP AP2005003347A patent/AP2005003347A0/xx unknown
- 2003-12-18 BR BR0317544-8A patent/BR0317544A/pt not_active Application Discontinuation
- 2003-12-18 KR KR1020127027784A patent/KR101361769B1/ko not_active Expired - Lifetime
- 2003-12-18 JP JP2005502554A patent/JP5475939B2/ja not_active Expired - Lifetime
- 2003-12-18 KR KR1020127026719A patent/KR20120118087A/ko not_active Withdrawn
- 2003-12-18 PL PL377710A patent/PL215257B1/pl unknown
- 2003-12-18 EP EP03789346A patent/EP1572233B1/en not_active Expired - Lifetime
- 2003-12-18 AT AT03789346T patent/ATE503492T1/de active
- 2003-12-18 DE DE60336581T patent/DE60336581D1/de not_active Expired - Lifetime
- 2003-12-18 WO PCT/EP2003/014562 patent/WO2004056389A1/en not_active Ceased
- 2003-12-18 EA EA200701633A patent/EA200701633A1/ru unknown
- 2003-12-18 NZ NZ540811A patent/NZ540811A/en not_active IP Right Cessation
- 2003-12-18 EA EA200500834A patent/EA009179B1/ru not_active IP Right Cessation
- 2003-12-18 OA OA1200500189A patent/OA13147A/en unknown
-
2005
- 2005-04-26 US US11/114,301 patent/US20050287161A1/en not_active Abandoned
- 2005-06-09 IL IL169085A patent/IL169085A/en active IP Right Grant
- 2005-06-09 IS IS7885A patent/IS2811B/is unknown
- 2005-06-13 NO NO20052846A patent/NO20052846L/no not_active Application Discontinuation
- 2005-06-20 EC EC2005005869A patent/ECSP055869A/es unknown
- 2005-07-18 MA MA28398A patent/MA27581A1/fr unknown
-
2011
- 2011-06-08 CY CY20111100549T patent/CY1111552T1/el unknown
-
2015
- 2015-12-09 BE BE2015C068C patent/BE2015C068I2/fr unknown
- 2015-12-09 BE BE2015C067C patent/BE2015C067I2/fr unknown
- 2015-12-09 BE BE2015C069C patent/BE2015C069I2/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006512413A5 (https=) | ||
| Lowy et al. | Prophylactic human papillomavirus vaccines | |
| Yousefi et al. | An update on human papilloma virus vaccines: history, types, protection, and efficacy | |
| EP1410805B1 (en) | Vaccine against HPV | |
| CA2510457A1 (en) | Hpv-16 and -18 l1 vlp vaccine | |
| Gambhira et al. | Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2 | |
| JP5623910B2 (ja) | ヒトパピローマウイルス感染症の治療又は予防のための複数型ｈｐｖペプチド組成物及び方法 | |
| EP2416798B1 (en) | Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines | |
| AU2008226974B2 (en) | Papillomavirus vaccine compositions | |
| JP2008534467A5 (https=) | ||
| Stanley | Prophylactic HPV vaccines | |
| Campo et al. | Papillomavirus prophylactic vaccines: established successes, new approaches | |
| Kalnin et al. | Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypes | |
| EA201170264A1 (ru) | Вакцина против hpv | |
| Roden et al. | The impact of preventive HPV vaccination | |
| JP2008539184A5 (https=) | ||
| JP2013540421A5 (https=) | ||
| JP2002532434A5 (https=) | ||
| EA202190441A1 (ru) | Терапия папилломавирусных инфекций человека высокого риска | |
| HRP20120930T1 (hr) | Cjepivo protiv hpv16 i hpv18 i još najmanje jednog tipa hpv, kojeg se bira između hpv31, 45 ili 52 | |
| Sultana | Human Papilloma Virus Vaccine for Cervical Cancer Prevention | |
| JP2008539182A5 (https=) | ||
| CN101116745B (zh) | 人乳头瘤病毒的病毒样颗粒疫苗 | |
| Takehara et al. | Human Papillomavirus Vaccine: Its Application and Perspective | |
| Cid-Arregui | Prophylactic HPV vaccines |